• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Michael Poku, MD, MBA

Latest:

Variation in Markups on Outpatient Oncology Services in the United States

Charges for oncology services vary widely across hospitals and impose financial burdens. Further legislation is needed to address disparities in access to high-quality cancer care.





Galina Inzhakova, MPH

Latest:

Potential of Risk-Based Population Guidelines to Reduce Cardiovascular Risk in a Large Integrated Health System

The authors evaluated the clinical applicability, accuracy, and implications of using an automated risk calculator and risk-based decision tool in an integrated health system.



Kelly F. Bell, PharmD, MSPhr

Latest:

Authors’ Reply to “Comment on Generalizability of GLP-1 RA CVOTs in US T2D Population”

The authors of the manuscript “Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials Enrollment Criteria to the US Type 2 Diabetes Population” respond to a letter to the editor.


Sue Levi, RN, MBA

Latest:

Implementation of EHR-Based Strategies to Improve Outpatient CAD Care

We examined the impact of electronic reminders followed by performance reports and financial incentives. Physicians responded more to reports and incentives than to reminders alone.


Deena J. Chisolm, PhD

Latest:

Implications of Eligibility Category Churn for Pediatric Payment in Medicaid

Analyses of Ohio Medicaid claims data from 2013 to 2015 reveal that instability among eligibility categories is common and affects average capitation but not health service use.


Kenneth Patric, MD

Latest:

Distal Upper and Lower Limb Fractures Associated With Thiazolidinedione Use

This study demonstrates that patients with diabetes taking thiazolidinediones have higher proportions of distal upper and lower limb fractures than those not taking the drug.




David Schutt, MD

Latest:

Characterizing Medical Care by Disease Phase in Metastatic Colorectal Cancer

This study characterized patterns and costs of medical care by disease phase in patients with newly diagnosed mCRC using a large US national commercially insured claims database.



Tricia Lee Wilkins, PharmD, PhD

Latest:

Adoption of Electronic Prescribing for Controlled Substances Among Providers and Pharmacies

We present the first reported national trends in the adoption of electronic prescription of controlled substances, from July 2012 to December 2013. The results show that the uptake rates of this newly allowed process are steadily increasing.



David E. Winchester, MD, MS

Latest:

Electronic Consults for Improving Specialty Care Access for Veterans

The combination of electronic consultations and active triage of specialty care consults effectively reduces wait times for outpatient clinics.


Michael S. Broder, MD

Latest:

Cost-Effectiveness of 21-Gene Assay in Node-Positive, Early-Stage Breast Cancer

A decision-analytic model was used to estimate cost-effectiveness of adopting a 21-gene assay in treatment decisions for women with early-stage N (1-3)/ER HER2-negative breast cancer.


Simonetta Scalvini, MD

Latest:

Healthcare Continuity From Hospital to Territory in Lombardy: TELEMACO Project

The TELEMACO project successfully used telemedicine to establish a healthcare continuity from hospital to territory in remote areas of the Lombardy region of Italy.


Marie E. Pokorny, RN, MSN, PhD

Latest:

Barriers to Transition of Obese Patients From Hospital to Community

This study explored barriers to the transition of obese patients from hospital to community as perceived by case managers, nursing home directors, and home health directors.



Raina M. Merchant, MD, MSHP

Latest:

State of Emergency Preparedness for US Health Insurance Plans

Health insurance plans serve a critical role in public health emergencies. The authors queried plans about issues related to emergency preparedness: infrastructure, adaptability, connectedness, and best practices.


Barbara Mintzes, PhD

Latest:

Medicine Reimbursement Recommendations in Canada, Australia, and Scotland

Pharmacoeconomic analyses appear to account for differences in recommendations made regarding public payment when national bodies consider the same drugs for the same indication.


Jay Bhattacharya, MD, PhD

Latest:

A Way Out of the Dismal Arithmetic of Hepatitis C Treatment

This special issue presents important new peer-reviewed research, covering issues ranging from access and the out-of-pocket costs of a treatment course, to the real-world consequences-both economic and clinical-of failing to treat.


Gregory W. Daniel, PhD, MPH, RPh

Latest:

Value-Based Arrangements May Be More Prevalent Than Assumed

We surveyed biopharmaceutical manufacturers and payers to understand the prevalence and characteristics of value-based payment arrangements, as well as their implementation obstacles and success factors.




Melanie E. Mouzoon, MD

Latest:

Improving Influenza Immunization in Pregnant Women and Healthcare Workers

Influenza vaccination rates in pregnant women and healthcare workers were increased with standing orders, vaccine advocates, and educational activities on influenza immunization.


Andrew Henry, BS

Latest:

Computed Tomography Scan Use Variation: Patient, Hospital, and Geographic Factors

We observed small-area variation in computed tomography scan use for inpatients in New York State, even after controlling for relevant patient and hospital characteristics.


© 2024 MJH Life Sciences
AJMC®
All rights reserved.